Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab

Publication Date

2019

Journal Title

Blood

Volume Number

133

Issue Number

19

Pages

2031 - 2042

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

General Internal Medicine

PMID

30842083

DOI

10.1182/blood-2018-08-870238

For the public and Northwell Health campuses

Share

COinS